Early and Late Neurological Complications after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation
Pere Barba(Universitat Autònoma de Barcelona), Jorge Sierra(Universitat Autònoma de Barcelona), Julio Delgado(Departament de Salut), David Valcárcel(Vall d'Hebron Hospital Universitari), Rodrigo Martino(Universitat Autònoma de Barcelona), Javier Briones(Hospital de Sant Pau), José Luís Piñana(Hospital Universitari i Politècnic La Fe), Salut Brunet(Institut Català d'Oncologia), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Luís Querol(Hospital de Sant Pau)
Cited by 89
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k